At the core of our mission is discovery—advancing fundamental research into the biological mechanisms that link aging and cancer. Aging reshapes immune function, tissue environments, inflammation, and cellular behavior in ways that dramatically increase cancer risk.
We support innovative, curiosity-driven science to uncover:
These discoveries form the foundation for everything that follows, revealing new opportunities to transform how cancer is understood, prevented, and treated.
Discovery alone is not enough. The Institute is committed to translating scientific insights into tools and therapies that improve patient outcomes.
We prioritize research that moves aging and cancer biology toward:
By accelerating the path from lab to clinic, we help ensure that breakthroughs in aging and cancer research lead to tangible benefits for patients.
The complexity of aging and cancer demands collaboration across disciplines, institutions, and borders. No single lab or field can solve this challenge alone.
The Institute brings together scientists with expertise in:
By fostering interdisciplinary and international collaboration, we break down silos and accelerate discoveries that would not be possible in isolation.
Strategic partnerships are essential to advancing a field as complex and underfunded as aging and cancer research. The Institute builds partnerships with academic institutions, research organizations, foundations, and governmental agencies to amplify impact.
Through these partnerships, we:
Together, we strengthen the global research ecosystem needed to address aging as the leading risk factor for cancer.
1350 Avenue of the Americas, Suite 2902
New York, NY 10019
(Tel) 212 867 4502